巨子 ICON - 財經股票資訊及專家分析
搜尋 股票

Applied Molecular Transport

AMTI
最少15分鐘延遲,股票資訊由第三方資訊供應商提供
・Applied Molecular Transport - 延遲價格・最後更新於 20/01 22:00
最高位
--
最低位
--
開市價
--
前收市價
9.310
成交量(千)
--
成交額(百萬)
--
買入
--
賣出
--
每手股數
--
市值(百萬)
358.34
市盈率
--
息率
--
差價
--
52週高低
78.220 - 9.260
所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

企業資料

公司名稱
Applied Molecular Transport
證券代碼
AMTI.US
所屬板塊
Biotechnology
公司業務
Applied Molecular Transport Inc is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Its proprietary technology platform allows it to exploit existing natural cellular trafficking pathways to facilitate the active transport of therapeutic payloads across the intestinal epithelium (IE) barrier. Its product candidate, AMT-101, is an oral IL-10 fusion protein that has been designed for active transport across the IE barrier into local GI tissue. IL-10 is a potent immunomodulatory cytokine that is known to be the master regulator of immune homeostasis, including within GI mucosal tissue.
發行量
38424662
公司總部
1 Tower Place, Suite 850
公司網址
https://www.appliedmt.com
公司電話
+1 650 392-0420
暫無內容

關於

Applied Molecular Transport(AMTI.US)所屬的行業板塊為Biotechnology。
Applied Molecular Transport Inc is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Its proprietary technology platform allows it to exploit existing natural cellular trafficking pathways to facilitate the active transport of therapeutic payloads across the intestinal epithelium (IE) barrier. Its product candidate, AMT-101, is an oral IL-10 fusion protein that has been designed for active transport across the IE barrier into local GI tissue. IL-10 is a potent immunomodulatory cytokine that is known to be the master regulator of immune homeostasis, including within GI mucosal tissue.
詳細公司背景可參考: https://www.appliedmt.com